Skip to content
Screener

Septerna, Inc. SEPN Asset turnover

Asset turnover at other companies

Amgen logo
AmgenAMGN
0.4×0.0×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
0.1×-0.5×
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
0.1×-0.1×
Schrodinger logo
SchrodingerSDGR
0.4×0.0×
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
0.9×-0.5×

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.78B+240%
Enterprise value$1.73B+383%
P/S24.7×-696×

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%—
Debt / equity0.1×—
Current ratio4.7×-27.5×

Where this comes from

Calculated from Septerna, Inc.’s reported figures.

total revenue/total assets=0.1×

Based on trailing twelve months.

The source filing: Septerna, Inc.’s 10-Q, filed May 11, 2026. Open the filing →

Filed
May 11, 2026, 4:08 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216759

FAQ

What is Septerna, Inc.'s asset turnover?
Septerna, Inc. (SEPN) reported asset turnover of 0.1× in Q1 2026.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Ask your AI about Septerna, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude